National regulatory association moves ahead with bid to own the .pharmacy domain
Continuing its years-long efforts to bring order to the online pharmacy world, the National Assn. of Boards of Pharmacy (NABP; Mt. Prospect, IL) has found in its latest surveying that almost 97% of over 10,758 sites investigated and reviewed by the organization do not meet basic laws and regulations for dispensing pharmaceuticals to consumers. The new report, Internet Drug Outlet Identification Program, is available at the NABP website.
Of the rogue sites, which NABP compiles in a “Not Recommended” list, the violations are widespread:
Of 104 sites newly added to the Not Recommended list, 28 provide controlled substances, and 18 more provide tramadol, an abused analgesic--both should be high concerns to drug-abuse authorities. NABP has a long-established program for accrediting online pharmacies under its VIPPS (Verified Internet Pharmacy Practice), Vet-VIPPS (for veterinarians) and e-Advertiser (for sites that provide refills or prescribing information, but don’t dispense first prescriptions) programs. As of March 31, 110 sites have one of these accreditations; NABP finds an additional 256 sites that do not violate online-prescribing norms, but lack accreditation from it.
Of particular interest to investigators and law enforcement, NABP finds that 1,529 sites have locations identified as being in the US; and 5,645 sites have servers physically inside the US. Policing the Internet is difficult, since parts of it operate supranationally; but when the business has a US location, it is accessible to law enforcement.
All of these conditions have existed for quite a while, and FDA and other law-enforcement agencies have not ignored them: FDA has been a participant in annual, international “Operation Pangea” programs, where Interpol, US Customs and Border Patrol, FDA and others simultaneously investigate, shut down and arrest violators around the world. The 2013 Operation Pangea netted 1,677 shutdowns of US-based sites. But as the NABP numbers attest, new sites can proliferate as quickly as old ones are shut down. The “Canadian pharmacy” ploy—where online pharmacies purport to be safe, Canadian-based organizations attractive to US consumers—is still widespread.
GLTD and .pharmacy
In the report, NABP includes an update of its ongoing effort to obtain control of the “.pharmacy” generic level top-domain suffix (gLTD—the word or letters after the dot in an Internet URL), which is being regulated by ICANN, the Internet Corporation for Assigned Names and Numbers. NABP is in the “contracting phase” of the ICANN process, and next steps include “execution of the registry agreement with ICANN … testing and contracting with registrars to ensure compliance with established pharmacy standards.” With this agreement in place, NABP and collaborating organizations will be able to control who gets to use the “.pharmacy” domain name and in time, hopefully, steer consumers to those sites in preference to the rogue sites.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.